500
Participants
Start Date
October 13, 2016
Primary Completion Date
May 8, 2017
Study Completion Date
May 19, 2017
Eravacycline
Meropenem
Placebo
Los Angeles
Indianapolis
Las Vegas
Somers Point
Cleveland
Columbus
Pleven
Plovdiv
Rousse
Sofia
Varna
Jihlava
Kladno
Kolín
Prague
Tallinn
Tartu
Viljandi
Võru
Batumi
Kutaisi
Tbilisi
Zugdidi
Győr
Kaposvár
Pécs
Veszprém
Daugavpils
Liepāja
Rēzekne
Riga
Kaunas
Klaipėda
Vilnius
Bucharest
Cluj-Napoca
Craiova
Târgu Mureş
Timișoara
Arkhangelsk
Kaluga
Krasnodar
Nizhny Novgorod
Saint Petersburg
Volgograd
Vsevolozhsk
Dnipro
Ivano-Frankivsk
Kharkiv
Kyiv
Lviv
Odesa
Uzhhorod
Vinnytsia
Tetraphase Pharmaceuticals, Inc
INDUSTRY